In pancreatic cancer, both CXCL10 and CXCR3 are expressed in tumor tissue (Delitto et al., 2015), and their presence has been correlated with poor prognosis (Liu et al., 2011; Lunardi et al., 2014). This evidence concerns the gene CXCR3 and familial pancreatic carcinoma.